• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于脂质的微管药物递送载体。

Lipid-based microtubular drug delivery vehicles.

作者信息

Meilander N J, Yu X, Ziats N P, Bellamkonda R V

机构信息

Biomaterials, Cell and Tissue Engineering Laboratory, Department of Biomedical Engineering, Case Western Reserve University, Cleveland, OH 44106-7207, USA.

出版信息

J Control Release. 2001 Mar 12;71(1):141-52. doi: 10.1016/s0168-3659(01)00214-0.

DOI:10.1016/s0168-3659(01)00214-0
PMID:11245915
Abstract

Lipid microtubules that self-assemble from a diacetylenic lipid are suitable structures for the sustained release of bioactive agents. Microtubules were loaded with agents under aqueous conditions and embedded in an agarose hydrogel for localization at areas of interest. Protein release from our microtubule-hydrogel delivery system was characterized in vitro, and in vivo biocompatibility was examined. The influences of protein molecular weight and initial loading concentration on release profile were evaluated by releasing test proteins myoglobin, albumin, and thyroglobulin. Protein molecular weight inversely affected the release rate, and loading with a higher protein concentration increased the mass but not the percent of initially loaded protein released daily. Preservation of protein activity was demonstrated by the ability of a neurotrophic factor released from the delivery system to induce neurite extension in PC12 cells. Bovine aortic smooth muscle cells co-cultured with the microtubule-hydrogel system showed no evidence of cytotoxicity and proliferated in the presence of the microtubules. Subcutaneous implantation of microtubules in rodents revealed no significant inflammatory response after 10 days. Our microtubule-hydrogel system is useful for applications where sustained release without contact between agent and organic solvents is desired.

摘要

由二乙炔脂质自组装形成的脂质微管是用于生物活性剂持续释放的合适结构。在水性条件下将微管用试剂加载,并嵌入琼脂糖水凝胶中以定位在感兴趣的区域。对我们的微管-水凝胶递送系统中的蛋白质释放进行了体外表征,并检测了体内生物相容性。通过释放测试蛋白肌红蛋白、白蛋白和甲状腺球蛋白,评估了蛋白质分子量和初始加载浓度对释放曲线的影响。蛋白质分子量对释放速率有反向影响,加载更高的蛋白质浓度会增加每日释放的初始加载蛋白质的质量,但不会增加其百分比。从递送系统释放的神经营养因子诱导PC12细胞中神经突延伸的能力证明了蛋白质活性的保留。与微管-水凝胶系统共培养的牛主动脉平滑肌细胞没有细胞毒性的迹象,并且在微管存在的情况下增殖。在啮齿动物中皮下植入微管10天后未发现明显的炎症反应。我们的微管-水凝胶系统可用于需要在试剂与有机溶剂不接触的情况下持续释放的应用。

相似文献

1
Lipid-based microtubular drug delivery vehicles.基于脂质的微管药物递送载体。
J Control Release. 2001 Mar 12;71(1):141-52. doi: 10.1016/s0168-3659(01)00214-0.
2
Sustained release of plasmid DNA using lipid microtubules and agarose hydrogel.利用脂质微管和琼脂糖水凝胶实现质粒DNA的缓释。
J Control Release. 2003 Mar 7;88(2):321-31. doi: 10.1016/s0168-3659(03)00007-5.
3
Biocompatibility and drug release behavior of spontaneously formed phospholipid polymer hydrogels.自发形成的磷脂聚合物水凝胶的生物相容性和药物释放行为
J Biomed Mater Res A. 2007 Jan;80(1):45-54. doi: 10.1002/jbm.a.30864.
4
Construction of Injectable Self-Healing Macroporous Hydrogels via a Template-Free Method for Tissue Engineering and Drug Delivery.通过无模板方法构建用于组织工程和药物输送的可注射自修复大孔水凝胶。
ACS Appl Mater Interfaces. 2018 Oct 31;10(43):36721-36732. doi: 10.1021/acsami.8b13077. Epub 2018 Oct 18.
5
PEG-PCL based micelle hydrogels as oral docetaxel delivery systems for breast cancer therapy.基于 PEG-PCL 的胶束水凝胶作为口服多西紫杉醇递药系统用于乳腺癌治疗。
Biomaterials. 2014 Aug;35(25):6972-85. doi: 10.1016/j.biomaterials.2014.04.099. Epub 2014 May 16.
6
Hydrogel-electrospun fiber composite materials for hydrophilic protein release.水凝胶-静电纺丝纤维复合材料用于亲水性蛋白质释放。
J Control Release. 2012 Feb 28;158(1):165-70. doi: 10.1016/j.jconrel.2011.09.094. Epub 2011 Oct 5.
7
pH-responsive self-healing injectable hydrogel based on N-carboxyethyl chitosan for hepatocellular carcinoma therapy.基于N-羧乙基壳聚糖的pH响应性自愈合可注射水凝胶用于肝细胞癌治疗
Acta Biomater. 2017 Aug;58:168-180. doi: 10.1016/j.actbio.2017.06.001. Epub 2017 Jun 2.
8
In vitro characterization of vascular endothelial growth factor and dexamethasone releasing hydrogels for implantable probe coatings.用于可植入探头涂层的血管内皮生长因子和地塞米松释放水凝胶的体外特性研究
Biomaterials. 2005 Jun;26(16):3285-97. doi: 10.1016/j.biomaterials.2004.07.069.
9
Towards controlled release of BDNF--manufacturing strategies for protein-loaded lipid implants and biocompatibility evaluation in the brain.迈向脑源性神经营养因子的控释——载蛋白脂质植入物的制造策略及脑内生物相容性评估
J Control Release. 2007 Jun 4;119(2):163-72. doi: 10.1016/j.jconrel.2007.02.005. Epub 2007 Feb 20.
10
Encapsulation of bovine serum albumin within novel xanthan gum based hydrogel for protein delivery.新型黄原胶基水凝胶包埋牛血清白蛋白用于蛋白质递送。
Mater Sci Eng C Mater Biol Appl. 2019 Jan 1;94:1044-1055. doi: 10.1016/j.msec.2018.10.040. Epub 2018 Oct 10.

引用本文的文献

1
Multiscale Experimental Evaluation of Agarose-Based Semi-Interpenetrating Polymer Network Hydrogels as Materials with Tunable Rheological and Transport Performance.基于琼脂糖的半互穿聚合物网络水凝胶作为具有可调流变学和传输性能材料的多尺度实验评估
Polymers (Basel). 2020 Oct 31;12(11):2561. doi: 10.3390/polym12112561.
2
An anchoring molecule increases intravitreal retention of antibody-based therapeutics used in the treatment of ocular diseases.一种锚定分子增加了用于治疗眼部疾病的基于抗体的治疗药物在眼内的保留。
J Control Release. 2020 Dec 10;328:263-275. doi: 10.1016/j.jconrel.2020.08.034. Epub 2020 Aug 25.
3
Biomaterials for Local, Controlled Drug Delivery to the Injured Spinal Cord.
用于局部、可控药物递送至脊髓损伤部位的生物材料。
Front Pharmacol. 2017 May 10;8:245. doi: 10.3389/fphar.2017.00245. eCollection 2017.
4
Combination therapy of stem cell derived neural progenitors and drug delivery of anti-inhibitory molecules for spinal cord injury.干细胞衍生神经祖细胞联合治疗与抗抑制分子药物递送用于脊髓损伤
Acta Biomater. 2015 Dec;28:23-32. doi: 10.1016/j.actbio.2015.09.018. Epub 2015 Sep 15.
5
Sustained dual drug delivery of anti-inhibitory molecules for treatment of spinal cord injury.用于治疗脊髓损伤的抗抑制分子的持续双药递送
J Control Release. 2015 Sep 10;213:103-111. doi: 10.1016/j.jconrel.2015.06.031. Epub 2015 Jun 27.
6
Enhanced therapeutic neovascularization by CD31-expressing cells and embryonic stem cell-derived endothelial cells engineered with chitosan hydrogel containing VEGF-releasing microtubes.通过表达CD31的细胞和用含有释放VEGF微管的壳聚糖水凝胶工程化的胚胎干细胞衍生内皮细胞增强治疗性血管新生。
Biomaterials. 2015 Sep;63:158-67. doi: 10.1016/j.biomaterials.2015.06.009. Epub 2015 Jun 11.
7
Effects of PEGylation on the physicochemical properties and in vivo distribution of organic nanotubes.聚乙二醇化对有机纳米管的物理化学性质及体内分布的影响。
Int J Nanomedicine. 2014 Dec 12;9:5811-23. doi: 10.2147/IJN.S75604. eCollection 2014.
8
Lipid tubule growth by osmotic pressure.渗透压驱动的脂管生长。
J R Soc Interface. 2013 Sep 4;10(88):20130637. doi: 10.1098/rsif.2013.0637. Print 2013 Nov 6.
9
Toward engineering a biological joint replacement.迈向生物关节置换工程。
J Knee Surg. 2012 Jul;25(3):187-96. doi: 10.1055/s-0032-1319783.
10
Tunable diacetylene polymerized shell microbubbles as ultrasound contrast agents.可调双乙炔聚合物壳层微泡作为超声造影剂。
Langmuir. 2012 Feb 28;28(8):3766-72. doi: 10.1021/la204510h. Epub 2012 Feb 14.